ICE Bioscience Overview
- Year Founded
-
2010
- Status
-
IPO Registration
- Employees
-
471
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
13
ICE Bioscience General Information
Description
Provider of integrated drug discovery and preclinical research services intended for biopharmaceutical companies, biotechnology firms, and research institutions. The company offers target validation, lead compound discovery, and pharmacology services, enabling drug developers to accelerate the identification of clinical candidates and optimize the drug development process.
Contact Information
Website
www.ice-biosci.comCorporate Office
- Building 15, Fengchuang Science and Technology Park
- No. 18, Kechuang 13th Street
- Beijing, 100176
- China
Corporate Office
- Building 15, Fengchuang Science and Technology Park
- No. 18, Kechuang 13th Street
- Beijing, 100176
- China
ICE Bioscience Timeline
ICE Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. IPO | 24-Jun-2026 | Announced | Profitable | |||
| 12. Secondary Transaction - Private | 24-Dec-2025 | Completed | Profitable | |||
| 11. IPO | 22-Jan-2025 | Completed | Profitable | |||
| 10. Secondary Transaction - Private | 25-Apr-2024 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B1) | 25-Apr-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 27-Sep-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A2) | 19-Jan-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 06-Sep-2022 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 23-Nov-2021 | $1.76M | $6.08M | Completed | Generating Revenue | |
| 4. Grant | 01-Aug-2021 | $1.08M | $6.08M | Completed | Generating Revenue |
ICE Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,985,294 | $2.35 | $2.35 | 1x | $2.35 | 10.34% | ||
| Ordinary | 740,740 | $0.93 | $0.93 | 1x | $0.93 | 3.86% |
ICE Bioscience Patents
ICE Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7942623-B2 | A potent and selective inhibitor of the calcium-activated potassium channel kca3.1 for use as a platform therapeutic agent. | Active | 30-Nov-2020 | ||
| JP-2024503571-A | A potent and selective inhibitor of the calcium-activated potassium channel kca3.1 for use as a platform therapeutic. | Active | 30-Nov-2020 | ||
| AU-2021387535-A1 | Potent and selective inhibitors of the calcium-activated potassium channel, kca3.1, for use as platform therapeutics | Pending | 30-Nov-2020 | ||
| AU-2021387535-A9 | Potent and selective inhibitors of the calcium-activated potassium channel, kca3.1, for use as platform therapeutics | Pending | 30-Nov-2020 | ||
| CA-3203637-A1 | Potent and selective inhibitors of the calcium-activated potassium channel, kca3.1, for use as platform therapeutics | Pending | 30-Nov-2020 | C07D211/90 |
ICE Bioscience Signals
ICE Bioscience Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing E-town International Industrial Investment Management | Government | Minority | ||
| Alwin Capital | Venture Capital | Minority | ||
| Shanghai Yuanjin Herun Private Equity Fund Management | Growth/Expansion | Minority | ||
| Addor Capital | Growth/Expansion | Minority | ||
| CICC Capital | PE/Buyout | Minority |
ICE Bioscience FAQs
-
When was ICE Bioscience founded?
ICE Bioscience was founded in 2010.
-
Where is ICE Bioscience headquartered?
ICE Bioscience is headquartered in Beijing, China.
-
What is the size of ICE Bioscience?
ICE Bioscience has 471 total employees.
-
What industry is ICE Bioscience in?
ICE Bioscience’s primary industry is Laboratory Services (Healthcare).
-
Is ICE Bioscience a private or public company?
ICE Bioscience is a Private company.
-
What is ICE Bioscience’s current revenue?
The current revenue for ICE Bioscience is .
-
How much funding has ICE Bioscience raised over time?
ICE Bioscience has raised $46.1M.
-
Who are ICE Bioscience’s investors?
Beijing E-town International Industrial Investment Management, Alwin Capital, Shanghai Yuanjin Herun Private Equity Fund Management, Addor Capital, and CICC Capital are 5 of 13 investors who have invested in ICE Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process